Is TB-500 Legal in Florida? How to Access It Legally

HealthRX.com

Florida law does not settle TB-500 access

Print or save as PDF

See the public record for TB-500

  • FDA approval / none; no approved product in Canada, Australia, the UK, the European countries FDA reviewed, or by the European Medicines Agency [1]
  • Compounding lists / on neither list; the category 1 no-action policy does not cover it [2][3][7]
  • Advisory committee / voted in favour on 23 July 2026; advice only, not binding [8][4]
  • HHS draft policy / filed 28 October 2026; names TB-500 acetate injection; not an approval [4][5]
  • Human data / no study giving TB-500 to a person [1]
  • Florida / Chapter 465 of the Florida Statutes covers pharmacy licensure and permits [6]

What TB-500 is and where it stands

TB-500 is a synthetic, N-acetylated 7-amino-acid fragment of thymosin beta-4 (residues 17 to 23), not the 43-amino-acid protein itself [1]. It sits in the 'nominated but withdrawn' table on FDA's page about bulk substances that may present significant safety risks (content dated 22 April 2026), which holds substances previously in category 2 whose nominators withdrew them; removal from category 2 was not a finding that it is safe [9]. FDA's stated concerns stay on record: no identified human exposure data, missing safety information, and immunogenicity risk from aggregation and peptide-related impurities in injectable peptides [9].

The July 2026 vote and the October 2026 draft

FDA's Pharmacy Compounding Advisory Committee reviewed TB-500 on 23 July 2026 and voted in favour of adding it to the bulks list, against FDA staff's recommendation; the vote is advice only, and adding it takes formal rulemaking [8][4].

A draft HHS enforcement-discretion policy filed on 28 October 2026 (Federal Register document 2026-22192, publication scheduled 30 October 2026, comments due two weeks later) names TB-500 among six peptides [4][5]. It covers TB-500 acetate given subcutaneously or intramuscularly and says HHS 'does not intend to take enforcement action' against a state-licensed pharmacy, federal facility or licensed physician compounding with it where conditions are met, such as a single active ingredient, a patient-specific prescription, an FDA-registered manufacturer with a certificate of analysis, and the label 'This is a compounded drug product. Not for resale.' [4][5]. The notice says the draft does not establish rights for any person, is not binding on HHS or the public, and may be revisited if a safety signal or product quality issue arises; compounded drugs are not FDA-approved [4].

What Florida adds

Chapter 465 of the Florida Statutes sets out pharmacy licensure, permits and general requirements, including a nonresident sterile compounding permit [6]. The chapter's contents list does not mention TB-500.

What is known about safety in humans

FDA's July 2026 review found no article in which TB-500 was given to a human, and none of the three papers the nominator cited involved it in humans; there is no approved dose and no human dosing study [1]. FDA's adverse-event database search through 26 March 2025 retrieved no TB-500 reports, and its food and supplement complaint system retrieved two cases about a blended TB-500 and BPC-157 product with no safety assessment [1]. A single case in FDA's BPC-157 review describes a 40-year-old woman who developed widespread skin hyperpigmentation and gum darkening within a week of using a research-purpose BPC-157 plus TB-500 (5 mg/5 mg) product subcutaneously twice daily, recurring when she retried it; because the product held two peptides, FDA could not tell whether either caused it [10].

Check what you know

Think you have it? Try 4 quick questions and see what the article says.

1. According to the article, how is TB-500 best described?

Question 1 of 4

Score: 0 right, 0 of 4 answered

Is TB-500 legal in Florida?
TB-500 is not FDA-approved and is on neither federal list of bulk substances for compounding [1][2][3]. The draft HHS policy naming TB-500 acetate injection is not an approval, is not binding and places TB-500 on no list [4][5]. Florida's Chapter 465 covers pharmacy licences and permits, including a nonresident sterile compounding permit [6], but that provision alone does not establish whether a Florida resident may obtain or possess TB-500.
Did FDA approve TB-500 after the July 2026 vote?
No. The Pharmacy Compounding Advisory Committee voted in favour of adding it to the bulks list against FDA staff's recommendation, but the advice is non-binding and adding it takes formal rulemaking [8][4].
Is TB-500 the same as thymosin beta-4?
No. TB-500 is a synthetic, N-acetylated 7-amino-acid fragment (residues 17 to 23) of the 43-amino-acid protein thymosin beta-4; trials of the full protein do not show that TB-500 works or is safe [1].
Show all 10 referencesHide references
Evidence overview for Is TB-500 Legal in Florida? How to Access It Legally